References
- Ball DW. Medullary thyroid cancer: therapeutic targets and molecular markers. Curr Opin Oncol 19, 18–23, 2007.10.1097/CCO.0b013e32801173ea17133107
- Darwish A, Satir AA, Hameed T, Malik S, Aqel N. Simultaneous medullary carcinoma, occult papillary carcinoma and lymphocytic thyroiditis. Malays J Pathol 17, 103–107, 1995.
- Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295, 2164–2167, 2006.10.1001/jama.295.18.216416684987
- Dikbas O, Duman AA, Guvendi GF. Medullary thyroid carcinoma and papillary thyroid carcinoma in the same patient as a Collision tumour. Case Rep Endocrinol 2019, 4038628, 2019.10.1155/2019/4038628643431230993022
- Fanipakdel A, Seilanian Toussi M, Rezazadeh F, Mohamadian Roshan N, Javadinia SA. Overexpression of cancer-testis antigen melanoma-associated antigen A1 in lung cancer: A novel biomarker for prognosis, and a possible target for immunotherapy. J Cell Physiol 234, 12080–12086, 2019.10.1002/jcp.2788430569450
- Guilmette J, Nose V. Hereditary and familial thyroid tumours. Histopathology 72, 70–81, 2018.10.1111/his.1337329239041
- Gurkan E, Gurbuz Y, Tarkun I, Canturk Z, Cetinarslan B. Mixed medullary-papillary carcinoma of the thyroid: report of two cases and review of the literature. Indian J Pathol Microbiol 57, 598–602, 2014.10.4103/0377-4929.14268425308015
- Jain M, Verma D, Thomas S, Chauhan R. Mixed medullary - papillary carcinoma thyroid: an uncommon variant of thyroid carcinoma. J Lab Physicians 6, 133–135, 2014.10.4103/0974-2727.141520419636425328343
- Javadinia SA, Shahidsales S, Fanipakdel A, Joudi-Mashhad M, Mehramiz M, Talebian S, Maftouh M, Mardani R, Hassanian SM, Khazaei M, Ferns GA, Avan A. Therapeutic potential of targeting the Wnt/β-catenin pathway in the treatment of pancreatic cancer. J Cell Biochem 2018. Epub ahead of print.10.1002/jcb.2783530368889
- Javadinia SA, Shahidsales S, Fanipakdel A, Mostafapour A, Joudi-Mashhad M, Ferns GA, Avan A. The esophageal cancer and the PI3K/AKT/mTOR signaling regulatory microRNAs: a novel marker for prognosis, and a possible target for immunotherapy. Curr Pharm Des 24, 4646–4651, 2018.10.2174/138161282566619011014325830636576
- Kakudo K, Bychkov A, Bai Y, Li Y, Liu Z, Jung CK. The new 4th edition World Health Organization classification for thyroid tumors, Asian perspectives. Pathol Int 68, 641–664, 2018.10.1111/pin.1273730537125
- Lamberg BA, Reissel P, Stenman S, Koivuniemi A, Ekbolm M, Makinen J, Franssila K. Concurrent medullary and papillary thyroid carcinoma in the same thyroid lobe and in siblings. Acta Med Scand 209, 421–424, 1981.10.1111/j.0954-6820.1981.tb11620.x7246276
- Moslehi M, Shahi Z, Badihian S, Jalalpour P, Sedghian M, Motamedi G, Tavakol G. Differentiated thyroid cancer in Iran - initial observations, histological features, management of the disease, and tumor recurrence: A review of 1689 cases. Indian J Cancer 53, 261–264, 2016.10.4103/0019-509X.19772728071623
- Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013, 965212, 2013.10.1155/2013/965212366449223737785
- Rossi S, Fugazzola L, De Pasquale L, Braidotti P, Cirello V, Beck-Peccoz P, Bosari S, Bastagli A. Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature. Endocr Relat Cancer 12, 281–289, 2005.10.1677/erc.1.0090115947103
- Sadat Alavi M, Azarpira N. Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumor with lymph node metastasis: A case report. J Med Case Rep 5, 590, 2011.10.1186/1752-1947-5-590328458222185367